icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
 
 
 
Genotypic and Phenotypic Characterization
of Clinical HCV NS5A Drug Resistance
 
 
  Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
 
WEBCAST of Themed Discussion - HCV
RAVs: http://www.croiwebcasts.org/console/player/29510?mediaType=audio&

CROI1

"NS5A RAVs were identified in 286/776 (36.9%) GT1a viruses and 85/197 (43.1%) GT1b viruses (Figure 1)......Of the 286 GT1a samples with RAVs, 165 (57.7%) harbored a single RAV and 121 (42.3%) had more than one RAV (Figure 2B)."

CROI2

CROI3

CROI4

CROI5

CROI6

CROI7

CROI8